Nutropin and Singulair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nutropin (somatropin [rdna origin]) and Singulair (montelukast sodium). Common drug interactions include flushing among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Nutropin and Singulair. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Nutropin?

Nutropin has active ingredients of somatropin [rdna origin]. eHealthMe is studying from 4,799 Nutropin users. Check the latest studies of Nutropin.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.



On Jul, 12, 2026

45 people who take Nutropin and Singulair together, and have interactions are studied.

Nutropin and Singulair drug interactions.

What are the common drug interactions of Nutropin and Singulair, by gender? *:

female:

  1. Flushing (the warm, red condition of human skin)
  2. Gastritis (inflammation of stomach)
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  5. Growth retardation (delayed growth)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Haemosiderosis (general increase in tissue iron stores without associated tissue damage)
  8. Heart rate increased
  9. Hospitalisation
  10. Hyperglycaemia (high blood sugar)

male:

  1. Abdominal pain upper
  2. Gait disturbance
  3. Application site oedema
  4. Application site reaction
  5. Arterial haemorrhage
  6. Arthralgia (joint pain)
  7. Cystic fibrosis (disease of the secretary glands)
  8. Dehydration (dryness resulting from the removal of water)
  9. Disturbance in attention
  10. Drug ineffective

What are the common drug interactions of Nutropin and Singulair, by age (0-1 to 60+)? *:

0-1:

  1. Anxiety
  2. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  3. Blood thyroid stimulating hormone increased
  4. Rhinorrhoea (watery mucus discharge from the nose)

2-9:

  1. Pancreatitis (inflammation of pancreas)
  2. Pain in extremity
  3. Burning sensation
  4. Injection site pain
  5. Mass
  6. Pain
  7. Dehydration (dryness resulting from the removal of water)
  8. Gait disturbance
  9. Gastritis (inflammation of stomach)
  10. Limb injury

10-19:

  1. Respiratory disorder (respiratory disease)
  2. Respiratory tract infection
  3. Rhinorrhoea (watery mucus discharge from the nose)
  4. Rhinovirus infection
  5. Scab (a hard coating on the skin formed during the wound healing)
  6. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  7. Seborrhoea (a disease of the sebaceous glands characterized by excessive secretion of sebum)
  8. Skin discolouration (change of skin colour)
  9. Slipped femoral epiphysis (upper part of femur slips from hip joint)
  10. Spinal compression fracture (fracture due to spinal compression on bone)

20-29:

  1. Vertigo
  2. Cardiac ventricular disorder (ventricular dysfunction of heart)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Fall
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  7. Loss of consciousness

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Gait disturbance
  2. Alopecia (absence of hair from areas of the body)
  3. Hypersensitivity
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Neuropathy peripheral (surface nerve damage)
  8. Pain in extremity
  9. Angiopathy (generic term for a disease of the blood vessels)
  10. Application site irritation

What are the existing conditions these people have? *

  1. Growth Hormone Deficiency: 17 people, 37.78%
  2. Immunodeficiency Common Variable: 4 people, 8.89%
  3. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 6.67%
  4. Hypersensitivity: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nutropin and Singulair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nutropin and Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nutropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nutropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on somatropin [rdna origin] and montelukast sodium (the active ingredients of Nutropin and Singulair, respectively), and Nutropin and Singulair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: